{"id":"https://openalex.org/W1018360976","doi":null,"title":"Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.","display_name":"Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.","publication_year":1998,"publication_date":"1998-05-01","ids":{"openalex":"https://openalex.org/W1018360976","mag":"1018360976","pmid":"https://pubmed.ncbi.nlm.nih.gov/9617505"},"language":"en","primary_location":{"id":"pmid:9617505","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9617505","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical neuropharmacology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105470203","display_name":"Montford F. Piercey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"M F Piercey","raw_affiliation_strings":["Pharmacia and Upjohn, Inc., Kalamazoo, Michigan 49001, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacia and Upjohn, Inc., Kalamazoo, Michigan 49001, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5105470203"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.4028,"has_fulltext":false,"cited_by_count":157,"citation_normalized_percentile":{"value":0.94440968,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"21","issue":"3","first_page":"141","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pramipexole","display_name":"pramipexole","score":1.0},{"id":"https://openalex.org/keywords/dopamine-d3-receptor","display_name":"dopamine D3 receptor","score":0.859000027179718},{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.7829999923706055},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.8759999871253967},{"id":"https://openalex.org/keywords/intrinsic-activity","display_name":"intrinsic activity","score":0.7799999713897705},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9789999723434448},{"id":"https://openalex.org/keywords/dopamine-metabolism","display_name":"dopamine metabolism","score":0.8999999761581421},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.8849999904632568}],"concepts":[{"id":"https://openalex.org/C2779989193","wikidata":"https://www.wikidata.org/wiki/Q421304","display_name":"Pramipexole","level":4,"score":0.9915754199028015},{"id":"https://openalex.org/C199596767","wikidata":"https://www.wikidata.org/wiki/Q21110872","display_name":"Dopamine receptor D3","level":4,"score":0.8159446716308594},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.6191520094871521},{"id":"https://openalex.org/C2778258207","wikidata":"https://www.wikidata.org/wiki/Q600203","display_name":"Dopamine agonist","level":4,"score":0.598863959312439},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.5863403677940369},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5815091729164124},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5758489370346069},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5535229444503784},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.5299283862113953},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40830880403518677},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.3338329792022705},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3331787586212158},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2776445150375366},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.20484241843223572}],"mesh":[{"descriptor_ui":"D000077487","descriptor_name":"Pramipexole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D050637","descriptor_name":"Receptors, Dopamine D3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052160","descriptor_name":"Benzothiazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9617505","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9617505","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical neuropharmacology","raw_type":"Journal Article"},{"id":"mag:1018360976","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9617505","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1911787150","https://openalex.org/W2068816850","https://openalex.org/W1996807063","https://openalex.org/W8997155","https://openalex.org/W1992343732","https://openalex.org/W2053042086","https://openalex.org/W2323640316","https://openalex.org/W148343220","https://openalex.org/W1995040824","https://openalex.org/W1972012028"],"abstract_inverted_index":{"Pramipexole":[0],"is":[1,168],"a":[2,149],"clinically":[3],"effective":[4],"nonergot":[5],"dopamine":[6,26,86,112],"agonist.":[7],"Pramipexole's":[8,121],"receptor":[9,34,57,95],"interactions":[10],"differ":[11],"from":[12],"ergot":[13],"agonists":[14],"in":[15,76,128,134,145],"several":[16,132],"ways.":[17],"First,":[18],"it":[19,50,80],"has":[20,37,51,81],"high":[21],"selectivity":[22],"for":[23,54,68,125,131,153],"interacting":[24],"with":[25,40,143,163],"D2":[27,48,87],"subfamily":[28,88],"receptors":[29],"(D2,":[30],"D3,":[31],"and":[32,36,73,98,116,139,166],"D4":[33],"subtypes)":[35],"little":[38],"interaction":[39],"adrenergic":[41],"or":[42],"serotonergic":[43],"receptors.":[44,89],"Second,":[45],"within":[46],"the":[47,55,135],"subfamily,":[49],"preferential":[52],"affinity":[53],"D3":[56],"subtype,":[58],"which,":[59],"according":[60],"to":[61,92],"preclinical":[62],"studies,":[63],"could":[64],"contribute":[65],"additional":[66],"efficacy":[67,124],"treatment":[69,127,154],"of":[70,111,118,137,155],"both":[71],"motor":[72],"psychiatric":[74],"syndromes":[75],"Parkinson's":[77,156],"disease.":[78],"Third,":[79],"full":[82],"intrinsic":[83],"activity":[84],"at":[85],"In":[90],"addition":[91],"pramipexole's":[93],"unusual":[94],"profile,":[96],"whole-animal":[97],"cell":[99],"culture":[100],"studies":[101],"suggest":[102],"that":[103],"pramipexole":[104,164],"might":[105],"provide":[106],"neuroprotective":[107],"effects":[108],"through":[109],"depression":[110],"metabolism,":[113],"antioxidant":[114],"effects,":[115],"stimulation":[117],"trophic":[119],"activity.":[120],"demonstrated":[122],"clinical":[123],"successful":[126],"early":[129],"disease":[130,147,157],"years":[133],"absence":[136],"L-dopa":[138,144,167],"as":[140,171],"adjunctive":[141],"therapy":[142,165],"late":[146],"suggests":[148],"potential":[150],"new":[151,159],"paradigm":[152],"whereby":[158],"patients":[160],"are":[161],"initiated":[162],"added":[169],"only":[170],"necessary.":[172]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}